NasdaqGM - Delayed Quote USD

Vera Therapeutics, Inc. (VERA)

39.95 +0.43 (+1.09%)
At close: April 24 at 4:00 PM EDT
39.96 +0.01 (+0.03%)
After hours: April 24 at 7:08 PM EDT

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current12/31/20239/30/20236/30/20233/31/2023
Market Cap 2.15B 683.38M 607.61M 710.39M 343.47M
Enterprise Value 2.04B 552.96M 456.68M 543.92M 260.10M
Trailing P/E -- -- -- -- --
Forward P/E -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- --
Price/Sales -- -- -- -- --
Price/Book 21.16 5.52 4.34 4.51 4.47
Enterprise Value/Revenue -- -- -- -- --
Enterprise Value/EBITDA -22.18 -22.48 -23.83 -28.26 -8.91
3/31/2023 - 5/14/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 12/31/2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -41.54%
Return on Equity (ttm) -107.50%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) -95.99M
Diluted EPS (ttm) -2.25
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 160.72M
Total Cash Per Share (mrq) 2.95
Total Debt (mrq) 53.71M
Total Debt/Equity (mrq) 52.82%
Current Ratio (mrq) 7.71
Book Value Per Share (mrq) 2.29

Cash Flow Statement

Operating Cash Flow (ttm) -92.18M
Levered Free Cash Flow (ttm) -62.13M

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52 Week Range 3 523.34%
S&P 500 52-Week Change 3 25.01%
52 Week High 3 50.78
52 Week Low 3 6.07
50-Day Moving Average 3 43.44
200-Day Moving Average 3 23.45

Share Statistics

Avg Vol (3 month) 3 1.42M
Avg Vol (10 day) 3 1.69M
Shares Outstanding 5 54.45M
Implied Shares Outstanding 6 54.45M
Float 8 39.88M
% Held by Insiders 1 7.95%
% Held by Institutions 1 87.27%
Shares Short (3/28/2024) 4 6.33M
Short Ratio (3/28/2024) 4 7.31
Short % of Float (3/28/2024) 4 17.20%
Short % of Shares Outstanding (3/28/2024) 4 11.62%
Shares Short (prior month 2/29/2024) 4 6.2M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers